Chemical information management in drug discovery:: Optimizing the computational and combinatorial chemistry interfaces

被引:60
作者
Oprea, TI [1 ]
Gottfries, J [1 ]
Sherbukhin, V [1 ]
Svensson, P [1 ]
Kühler, TC [1 ]
机构
[1] AstraZeneca R&D, Dept Med Chem, S-43183 Molndal, Sweden
关键词
chemical filters; property filters; scoring functions; property-based compound selection; combinatorial library design; drug-like; interactive visualization; diversity;
D O I
10.1016/S1093-3263(00)00066-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Structure-property relationships, central to many of today's drug discovery strategies, are not straightforward to deal with when trying to predict drug efficacy, that is, the combined outcome of target affinity, pharmacodynamic behavior, pharmacokinetic properties, and metabolic fate. In this article, we discuss the handling of chemical property information in reagents-for-synthesis selection, enumeration, and virtual library construction. We describe the use of diversity assessment and/or experimental design in selection of compound-libraries-to-be-synthesized. Our overall objective was to identify good-quality drug candidates through reliable structure-activity relationship data, with the minimum number of compounds synthesized and tested. Chemical filters, property filters, scoring functions, and utilization of interactive visualization tools are discussed. The concept of chemical diversity and aspects of chemical space navigation employing a proprietary tool, Chemical Global Positioning System (ChemGPS), for mapping the drug-related chemical space are examined. Guidelines and workflow recommendations for the practicing medicinal chemist are proposed.
引用
收藏
页码:512 / +
页数:14
相关论文
共 78 条
[1]  
AHLBERG C, 1994, HUMAN FACTORS IN COMPUTING SYSTEMS, CHI '94 CONFERENCE PROCEEDINGS - CELEBRATING INTERDEPENDENCE, P313, DOI 10.1145/191666.191775
[2]  
Ahlberg C., 1992, CHI '92 Conference Proceedings. ACM Conference on Human Factors in Computing Systems. Striking a Balance, P619, DOI 10.1145/142750.143054
[3]  
AHLBERG C, 1993, SPARKS INNOVATION HU
[4]   Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? [J].
Ajay ;
Walters, WP ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3314-3324
[5]   PERIPHERAL VASCULAR EFFECTS OF NORADRENALINE, ISOPROPYLNORADRENALINE AND DOPAMINE [J].
ALLWOOD, MJ ;
GINSBURG, J ;
COBBOLD, AF .
BRITISH MEDICAL BULLETIN, 1963, 19 (02) :132-&
[6]  
AUSTEL V, 1995, METH PRIN MED CHEM, V2, P49
[7]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[8]  
Baecker Ronald M., 1995, READINGS HUMAN COMPU
[9]  
Barnard JM, 1997, PERSPECT DRUG DISCOV, V7-8, P13
[10]  
Box GEP., 1978, Statistics for experimenters